AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Lilly’s $7 Billion Kelonia Deal Signals a New Phase for In Vivo Cell Therapy
Eli Lilly’s reported $7 billion acquisition of Kelonia marks one of the biggest bets yet on in vivo CAR-T, a strategy that aims to engineer cells inside the body rather than outside it. The deal underscores how quickly pharma is moving from AI-assisted discovery into ambitious therapeutic platforms that could reshape oncology and autoimmune care.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.